Baxalta Incorporated (BXLT) Q2 Revenue Tops Views, Offers Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Baxalta Incorporated (BXLT) Announces Expanded HYQVIA Coverage from CMS
August 3, 2015 8:36 AM EDTBaxalta Incorporated (NYSE: BXLT) announced that the Centers for Medicare and Medicaid Services (CMS) have expanded coverage to include in-home use of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], a treatment for adults with primary immunodeficiency (PI).
PI is the name for a group of more than 200 diseases wherein part of the persons immune system is missing or not functioning correctly.1 People with PI may be more likely to get infections, take longer to recover from... More
